Climb Bio (CLYM) Income from Non-Controlling Interests (2020 - 2022)

Climb Bio (CLYM) has 3 years of Income from Non-Controlling Interests data on file, last reported at -$13.6 million in Q1 2022.

• Quarterly Income from Non-Controlling Interests rose 26.87% year-over-year to -$13.6 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was -$52.5 million (changed N/A YoY) and the FY2021 annual result came in at -$47.6 million, down 130.32% from the prior year.
• Income from Non-Controlling Interests eased to -$13.6 million in Q1 2022, from -$10.6 million in the prior quarter.
• In the past five years, Income from Non-Controlling Interests ranged from a high of -$2.3 million in Q3 2020 to a low of -$18.6 million in Q1 2021.
• A 3-year average of -$11.6 million and a median of -$12.1 million in 2021 frame the typical range for Income from Non-Controlling Interests.
• The widest YoY moves for Income from Non-Controlling Interests: up 28.35% in 2021, down 326.62% in 2021.
• Tracing CLYM's Income from Non-Controlling Interests over 3 years: stood at -$14.9 million in 2020, then gained by 28.35% to -$10.6 million in 2021, then fell by 27.72% to -$13.6 million in 2022.
• The last three Income from Non-Controlling Interests figures came in at -$13.6 million (Q1 2022), -$10.6 million (Q4 2021), and -$9.6 million (Q3 2021), per Business Quant data.